How should clinicians reassess early response to suzetrigine in acute pain (Medscape AI)

https://www.medscape.com/ai-search?query=How%20should%20clinicians%20reassess%20early%20response%20to%20suzetrigine%20in%20acute%20pain&ecd=wnl_tp10_daily_251226_MSCPEDIT_etid7988671&uac=148436CN&impID=7988671 Clinicians initiating suzetrigine for acute pain should perform an early reassessment within 48–72 hours of starting therapy to determine efficacy and guide further management.